Technology and Oncology Podcast Powered by Carevive

The OCM (Oncology Care Model), launched in 2016, is a payment model designed to help oncology centers transition from the traditional Medicare Fee-for-Service (FFS) payment structure and focus on high-value care.

The EOM (Enhancing Oncology Model) is the next phase model and will replace OCM starting July 1, 2023. EOM will support clinicians caring for patients with seven common cancer types, focusing on health equity and accountable, affordable care.

But what are the revenue-enhancing opportunities in EOM, is it worth the transition from OCM, and what does it actually provide?

On today’s episode of Technology and Oncology Podcast, host Michelle Dawn Mooney speaks with John Elliot, the Vice President of Sales at Carevive to discuss how oncology centers and clinics can transition from OCM to EOM and how they can get assistance for the process.

Michelle Dawn Mooney and John Elliot discussed:

  1. What clients should expect after approval and assistance available to meet the July 1 deadline for launching
  2. Benefits of EOM to oncology patients
  3. Where people can find more information and assistance on the topic

“Looking at oncology, efficiency is key, however, there are limited constrained resources. 24/7 access to electronic records, having a line of communication, capturing symptoms at the right time, access to care with the focus of addressing challenges in the oncology and health care sector which can improve patient outcome and reduce cost – this is what the EOM aims to achieve. The EOM model bridges the gap of communication and ensures members of the care team are aware of what is happening in real-time, which promotes standardization of care,” explained John Elliot.

John Elliot is the Vice President of Sales at Carevive. He received his Bachelor of Arts degree in Advertising from Southern Methodist University and his Master of Business Administration from Washington University in St. Louis-Olin Business School. He has over ten years of experience working with oncology centers.

Follow us on social media for the latest updates in B2B!

Image

Latest

Larry North
Resilience, Reinvention, and the Relentless Pursuit of Growth: Larry North’s Journey from Fitness Icon to Private Equity Leader
February 20, 2026

Entrepreneurship is being glamorized in real time. Social media highlights overnight wins, AI tools promise instant scale, and private equity is reshaping industries at a rapid clip. Yet behind every “success story” is something far less flashy: failure, adaptability, and the discipline to keep going when life hits hard. According to the U.S. Bureau…

Read More
Consulting
Consulting Reframed: Perspective, Leadership, and Impact Beyond the Client
February 19, 2026

As organizations navigate accelerating digital transformation, tighter margins, and increasing organizational complexity, the role of consultants is being re-examined. Today’s most effective consulting leaders are no longer valued simply for delivering projects, but for bringing outside perspective, cross-industry insight, and the ability to lead through ambiguity. Most large organizations today are not short on…

Read More
comedy
Laughter as a Service: How Comedy Can Power Trust, Teamwork, and Career Growth
February 19, 2026

Comedy might be the most underused business skill in your toolkit… In a world of back-to-back Zoom calls, Slack threads, and AI-generated everything, real human connection can start to feel like an afterthought. We’re moving faster than ever, but sometimes we’re listening less, reacting more, and missing the small moments that actually build trust. The…

Read More
founder-led brand
The Art of Evolution: Leading a Founder-Led Brand Into Its Next Chapter with Mary Beth Sheridan
February 19, 2026

For many retail brands, growth today isn’t just about innovation — it’s about keeping pace with customers whose expectations are evolving in real time, led by younger generations who expect brands to reflect their values and show up with cultural relevance. In fact, recent research from MG2 found that the overwhelming majority of Gen Z…

Read More